[EN] NYSTATIN FORMULATION HAVING REDUCED TOXICITY<br/>[FR] FORMULATION DE NYSTATINE A TOXICITE REDUITE
申请人:WISCONSIN ALUMNI RES FOUND
公开号:WO2001068102A2
公开(公告)日:2001-09-20
The present invention provides a novel formulation of nystatin for parenteral administration to treat systemic fungal infections. The formulation avoids the toxicity and solubility problems of prior art nystatin formulations.
[EN] NATAMYCIN COMPOSITIONS AND USES THEREOF<br/>[FR] COMPOSITIONS DE NATAMYCINE ET UTILISATIONS DE CELLES-CI
申请人:AREC CROP PROT B V
公开号:WO2017183972A1
公开(公告)日:2017-10-26
Provided is a particular form of natamycin that shows improved properties as a fungicide for use in agricultural applications. A preferred natamycin composition comprises a structuring agent and a surfactant, Said natamycin composition further comprises cellular matter from a natamycin-producing organism. The natamycin in a natamycin composition preferably has a surface area of less than 6m2/g, and an average particle size of less than 6 micrometer. The invention further relates to methods, comprising contacting a plant or part thereof, a fungus, a fruit, a crop, a seed, and/or a soil with a natamycin composition of the invention.
Sch 38518 and Sch 39185: two novel macrolactam antifungals
作者:Vinod R. Hegde、Mahesh G. Patel、Vincent P. Gullo、Mohindar S. Puar
DOI:10.1039/c39910000810
日期:——
The structures of Sch 38518 and Sch 39185, two antifungals isolated from the fermentation broth of an Actinomadura vulgaris subsp. vulgaris, have been assigned as macrocyclic lactam structures based on chemical transformations and spectroscopic data.